Bteich Michel
Department of Environmental and Occupational Health, School of Public Health, Université de Montréal, Montréal, Québec, Canada.
Heliyon. 2019 Nov 21;5(11):e02879. doi: 10.1016/j.heliyon.2019.e02879. eCollection 2019 Nov.
Although Albumin (ALB) and alpha-1-acid glycoprotein (AGP) have distinctive structural and functional characteristics, they both play a key role in binding a large variety of endogenous and exogenous ligands. An extensive binding to these plasma proteins could have a potential impact on drugs disposition (e.g. bioavailability, distribution and clearance), on their innocuity and their efficacy. This review summarizes the common knowledge about the structural and molecular characteristics of both ALB and AGP in humans, and about the most involved amino acids in their high-affinity binding pockets. However, the variability in residues found in binding pockets, for the same species, allows each plasma protein to interact differently with the ligands. The protein-ligand interaction influences differently the disposition of drugs that bind to either of these plasma proteins. The content of this review is useful for the design of new drug entities with high-binding characteristics, in qualitative and quantitative modelling (e.g. extrapolations, 3D molecular docking, interspecies extrapolations), and for other interdisciplinary research.
尽管白蛋白(ALB)和α-1-酸性糖蛋白(AGP)具有独特的结构和功能特征,但它们在结合多种内源性和外源性配体方面均发挥着关键作用。与这些血浆蛋白的广泛结合可能会对药物处置(如生物利用度、分布和清除率)、药物的安全性及其疗效产生潜在影响。本综述总结了关于人类ALB和AGP的结构和分子特征,以及它们高亲和力结合口袋中最相关氨基酸的常见知识。然而,同一物种在结合口袋中发现的残基变异性使得每种血浆蛋白与配体的相互作用方式不同。蛋白质-配体相互作用对与这些血浆蛋白中任何一种结合的药物处置产生不同影响。本综述的内容对于设计具有高结合特性的新药实体、定性和定量建模(如外推、三维分子对接、种间外推)以及其他跨学科研究都很有用。